血管医学および外科ジャーナル

概要

Why is an IABP not the Answer to Cardiogenic Shock after Percutaneous Coronary Intervention? Is it that Noradrenaline helps, Especially by Improving the RV Function in Addition to LV Function? A View Point

Prabha Nini Gupta, Ullas R Mullamalla, Praveen Velappan, Gopakumar KS, Faeez Mohamad Ali, B Krishana Kumar and Krishna Kumar P

We review the role of noradrenaline in cardiogenic shock. We describe our experience with the same after percutaneous coronary intervention, mostly primary angioplasty
The side effects of noradrenaline, the results of the SOAP 2 and the IABP Shock trial are also discussed. Noradrenaline is surprisingly a useful drug. So we want to share our experience with it.